HIV

HIV patients should switch to long-acting antiretroviral injectable treatments sooner, study concludes

Researchers found that 98% of patients who were not virally suppressed at the start of the study had non-detectable viral loads after 11 months of long-acting antiretroviral injectable treatment.…

The role of pharmacy in HIV pre-exposure prophylaxis

Pharmacists can play an important role in identifying and engaging with at risk individuals to promote PrEP awareness and uptake.…

PrEP pilot underway in five community pharmacies across south west England

The University of Bristol-led pilot is aimed to address inequalities in access to pre-exposure prophylaxis.…

Access to PrEP from community pharmacies could be piloted from autumn 2025

Exclusive: The Welsh government said it would explore pharmacist involvement in a pilot scheme designed to improve access to pre-exposure prophylaxis in the community.…

RPS raises concerns after draft HIV guidance recommends unregulated website for purchasing PrEP

The guidance suggests options to patients who are unable or unwilling to access PrEP on the NHS and calls for community pharmacies to “support greater equity” in accessing the drug.…

NICE rejects cabotegravir for PrEP in draft guidance

Draft guidance said the HIV pre-exposure prophylaxis (PrEP) treatment cabotegravir is not recommended because “it is not possible to determine the cost-effectiveness estimate ... without further analyses from the manufacturer”.…

Regulator approves first injectable treatment for prevention of HIV

Cabotegravir has been approved as pre-exposure prophylaxis in the UK in both tablet and injectable form.…

Pilots to provide PrEP via pharmacies only ‘possible future opportunities’, report warns

A report from the HIV Action Plan Implementation Steering Group said it was “concerning that the current proposal for PrEP pilots is marked as ‘possible future opportunities’”.…

PrEP highly effective in cutting HIV transmission but better access needed, study finds

Results of the 'PrEP Impact' trial show that PrEP reduced the chances of someone getting HIV by around 87%.…

Community pharmacy staff asked for views on provision of PrEP as part of NIHR research project

The University of Bristol is conducting research on the barriers community pharmacies must overcome if they are to provide HIV pre-exposure prophylaxis.…